Dunad Therapeutics leverages proprietary, tunable covalent chemistry to create innovative therapeutic solutions aimed at selectively and durably targeting the underlying drivers of diseases. This approach allows for the development of transformational medicines that can effectively address specific disease mechanisms, enhancing the precision and efficacy of treatments. By integrating advanced chemical techniques with a comprehensive understanding of disease biology, Dunad Therapeutics is positioned to pioneer new therapeutic avenues that could significantly improve patient outcomes.

The company's focus on covalent chemistry enables the design of molecules that can form stable bonds with target proteins, thereby modulating their activity in a controlled manner. This technology not only enhances the selectivity of the drugs but also contributes to their durability, potentially leading to longer-lasting therapeutic effects. By combining these advanced chemical strategies with insights into the biological pathways involved in various diseases, Dunad Therapeutics aims to develop next-generation therapies that address unmet medical needs and improve the quality of life for patients.

United Kingdom

Dunad Therapeutics is focusing on the development of next-generation targeted protein degradation therapies. Dunad’s platform enables selective degradation viadirect target modification using tuneable mono-valent small molecules, unlocking new target space and allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.

Dunad Therapeutics

Company Details